Photo by nci from unsplash
e20082Background: CNS recurrence is a devastating outcome after treatment of DLBCL. Clinical features poorly predict CNS recurrence risk or the need for prophylactic therapy. We examined whether sp... Click to show full abstract
e20082Background: CNS recurrence is a devastating outcome after treatment of DLBCL. Clinical features poorly predict CNS recurrence risk or the need for prophylactic therapy. We examined whether sp...
Keywords:
molecular predictors;
dlbcl;
recurrence;
central nervous;
predictors central;
cns recurrence
Journal Title: Journal of Clinical Oncology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!